International Patent: ANTI-GP350 AND ANTI-GP42 EPSTEIN BARR VIRUS ANTIBODIES AND USES OF THE SAME

GENEVA, Oct. 1 -- FRED HUTCHINSON CANCER CENTER filed a patent application (US2026/019174) for “ANTI-GP350 AND ANTI-GP42 EPSTEIN BARR VIRUS ANTIBODIES AND USES OF THE SAME”. With publication no. WO/2026/193438, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/085

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....